Showing results (291-300 of 303) with videos related to

Sort By:
Pageof 31
Archives of Otolaryngology--Head & Neck Surgery|April 18, 2012
A novel modular polymer platform for the treatment of head and neck squamous cell carcinoma in an animal modelDavid Hu, Ontario D Lau, Linda Wang, et al.
Current Neuropharmacology|December 11, 2023
Redox Modulation of Meniere Disease by Coriolus versicolor Treatment, a Nutritional Mushroom Approach with Neuroprotective PotentialRosanna Di Paola, Rosalba Siracusa, Roberta Fusco, et al.
Medicina (Kaunas, Lithuania)|November 25, 2023
Polyphenols in Inner Ear Neurobiology, Health and Disease: From Bench to ClinicsNaomi Osakabe, Sergio Modafferi, Maria Laura Ontario, et al.
Oncogene|August 27, 2013
Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cellsZ Chen, J Chen, Y Gu, et al.
Current Neuropharmacology|August 18, 2023
Antioxidants, Hormetic Nutrition, and AutismSergio Modafferi, Gabriella Lupo, Mario Tomasello, et al.
The Journal of Biological Chemistry|February 14, 1997
Involvement of p130(Cas) and p105(HEF1), a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cellsS N Manié, A R Beck, A Astier, et al.
Oncogene|February 2, 1999
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motilityR Salgia, J L Li, D S Ewaniuk, et al.
Leukemia|September 17, 2010
Smac mimetics: implications for enhancement of targeted therapies in leukemiaE Weisberg, A Ray, R Barrett, et al.
Leukemia|April 4, 2012
Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitorsE Weisberg, Q Liu, Erik Nelson, et al.
Scientific Reports|July 30, 2024
Distinct alterations in probabilistic reversal learning across at-risk mental state, first episode psychosis and persistent schizophreniaJ D Griffin, K M J Diederen, J Haarsma, et al.
Pageof 31